Tiny study probes key player in blood vessel health

NCT ID NCT02086253

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how a natural chemical called endothelin-1 affects the widening of arteries in response to increased blood flow. Eight healthy young men received drugs that block specific receptors for endothelin-1 to see how their arteries reacted. The goal was to better understand blood vessel function, which could help explain problems in conditions like high blood pressure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BQ-788 and/or BQ-123

What this could lead to

If successful, this could help explain why blood vessels don't widen properly in conditions like high blood pressure, pointing toward new treatment targets.

What could go wrong

This is a very small, early study in only 8 healthy young men, so results may not apply to older or sicker people. It is designed to gather knowledge, not test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY CONDITIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU - Hôpitaux de Rouen

    Rouen, Normandy, 76031, France